Curocell

Curocell is a pioneering cell therapy company dedicated to the discovery and development of innovative CAR-T therapies for the treatment of cancer. With a focus on harnessing the power of the body’s immune system, Curocell is committed to creating broad-spectrum CAR-T technologies to combat both blood cancers and solid tumors.

Located at 48 ,Yuseong-daero 1184beon-gil, Yuseong-gu, Daejeon, 34109, KR, Curocell is distinguished by its incorporation of advanced T cell modifying technology. This innovative approach is designed to effectively overcome immune suppression, leading to greater efficacy compared to current CAR-T cell technologies. Additionally, Curocell also has offices at 81, Irwon-ro, Gangnam-gu, B1, Future medicine center, Seoul, 06351, KR, and 200, Baumoe-ro, Seocho-gu 2F, Seoul, 06747, KR.

Curocell is dedicated to advancing the field of immune cell therapy and improving patient outcomes through its cutting-edge research and development efforts. We invite the manager of Curocell to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.